Autoimmune Diseases / 2018 / Article / Tab 1

Research Article

Identification of Levels of Serum Amyloid A and Apolipoprotein A1 in Serum Proteomic Analysis of Neuropsychiatric Systemic Lupus Erythematosus Patients

Table 1

Study groups and clinical characteristics of the patients. The study groups were the following: NPSLE (Neuropsychiatric Systemic Lupus Erythematosus), SLE (Systemic Lupus Erythematosus), NPnoSLE (Neuropsychiatric syndromes not associated with SLE), and CTRL (healthy controls). The characteristics compared among the groups were the median and IQR of the age (in years), sex (female or male), and the median and IQR of the SLEDAI, SANS, and SAPS scales. SLEDAI = Systemic Lupus Erythematosus Disease Activity Index; SANS = Scale for the Assessment of Negative Symptoms; SAPS = Scale for the Assessment of Positive Symptoms.

GROUPAGE (YEARS)SEX (F/M)SLEDAI, SANS and SAPS
MEDIAN; IQRMEDIAN; IQR

NPSLE929 y; 319/0SLEDAI 22; 10,5

SLE927 y; 18,59/0SLEDAI 12; 11,5

NPnoSLE930 y; 243/6SANS 42; 44,25
SAPS 18,5; 23,25

CTRL924 y; 20,59/0N/A

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.